{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"tirzepatide-skin","title":"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions","body":"## What's breaking down\n\nSkin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that does not retract fully. Inflammatory skin diseases such as psoriasis or hidradenitis suppurativa can worsen with metabolic stress and excess weight. These processes reflect degeneration outpacing the skin's ability to maintain firmness and barrier function. Tirzepatide targets body weight and glucose control; any skin discussion centers on whether those changes support or challenge skin integrity.\n\n## Why Tirzepatide might help you\n\n1. What keeps failing: Excess body weight maintains mechanical stretch on skin while metabolic factors sustain low-grade inflammation that impairs collagen maintenance.\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP pathways linked to substantial weight reduction (typically 15-20% body weight in trials) and improved glycemic control.\n3. Therefore for you: If excess weight or related inflammation forms part of the skin issue, Tirzepatide is examined because it addresses the metabolic load layer through fat reduction rather than directly altering skin cells or masking symptoms.\n\nWeight loss of this magnitude decreases compressive forces on tissues overall. For skin specifically, less subcutaneous fat can reveal or accentuate laxity in areas previously supported by adipose tissue. The same pathway may lower systemic inflammation that contributes to certain dermatologic conditions.\n\n## How these fit together\n\nSingle-compound focus. Tirzepatide acts on the metabolic load and body weight layer. Any skin outcome—whether reduced inflammatory drive in conditions like psoriasis or increased laxity from rapid fat loss—stems from that primary action. No sibling compounds appear in scope to address separate layers such as direct collagen synthesis or sleep-mediated repair.\n\n## What the evidence actually shows\n\nHuman trial data from SURPASS and SURMOUNT programs demonstrate consistent weight loss but do not report primary skin repair endpoints. FAERS pharmacovigilance analysis of GLP-1 agonists (including tirzepatide) recorded dermatologic events in roughly 6% of reports, with rash, pruritus, and alopecia among the most frequent. A 2025 narrative review in Anais Brasileiros de Dermatologia summarized cutaneous adverse events and noted emerging case reports for hidradenitis suppurativa improvement. Phase 3 trials TOGETHER-PsO and TOGETHER-PsA are underway for psoriasis and psoriatic arthritis; results expected 2026. No large randomized human trials yet confirm direct collagen or elasticity gains from tirzepatide. Preclinical and mechanistic observations link rapid weight loss to altered collagen fiber ratios and reduced skin firmness due to loss of fat padding. Reddit threads describe loose skin, facial volume changes, occasional acne clearance, and transient burning sensations. X posts echo similar anecdotal patterns of sagging or improved inflammatory skin appearance, though volume remains limited. Evidence inventory: multiple human weight-loss trials and FAERS reports (human tier), case series and ongoing trials (human tier), mechanistic descriptions of fat loss effects (mechanistic tier), user reports (anecdotal tier). No rat skin-specific tirzepatide studies identified in searches.\n\n## What scientists say\n\nReviews note that tirzepatide-induced weight loss can produce aesthetic skin changes secondary to volume reduction, similar to post-bariatric outcomes. Immunomodulatory effects via GLP-1 signaling are hypothesized to benefit inflammatory dermatoses, but data stay preliminary. Experts emphasize that skin adaptation lags behind fat loss, particularly after age 40 or with long-standing obesity. Ongoing trials will clarify whether metabolic improvement translates to measurable skin clearance beyond weight effects.\n\n## What people say on Reddit\n\nUsers report loose or sagging skin after significant loss, sometimes describing an aged appearance in face and body. Some note clearing of cystic acne or eczema-like symptoms. Injection-site reactions, allodynia, and transient burning sensations appear in multiple threads. Others mention hair shedding or facial hollowing. Positive skin stories often tie to overall health gains rather than direct dermatologic action. Experiences vary widely by dose, duration, age, and prior skin condition.\n\n## What people say on X\n\nPosts reference \"Ozempic face\" or Zepbound-related sagging, with some users celebrating reduced inflammation in psoriasis or HS. Complaints center on unexpected laxity despite health improvements. Anecdotes about clearer skin or new sensitivities circulate but lack systematic tracking. Volume of skin-specific discussion remains lower than general weight-loss threads.\n\n## What we do not know\n\nLong-term effects on skin elasticity and collagen remodeling after sustained tirzepatide use remain unquantified in large human cohorts. Whether benefits in inflammatory skin disease stem from weight loss, direct receptor action, or both is unresolved. Optimal strategies to support skin during rapid loss (nutrition, resistance training, topical care) lack dedicated tirzepatide trials. Differential impact by age, sex, duration of obesity, and genetics is not delineated.\n\n## Safety and limits\n\nCommon cutaneous reports include injection-site reactions and generalized rashes. Alopecia and pruritus appear in pharmacovigilance data. Rapid weight loss itself carries risk of visible laxity regardless of method. Tirzepatide is not indicated or studied as a primary skin treatment. All observations require individual medical evaluation; no dosing or therapeutic recommendations are implied.\n","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tirzepatide-skin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Tirzepatide produces 15-20% body weight reduction in clinical trials.","section":"Why Tirzepatide might help you","tier":"human","source_ids":["web:24"],"source_status":"sourced","why_material":"Establishes magnitude of weight change that can affect skin support.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"FAERS data show dermatologic adverse events in ~6% of GLP-1 agonist reports, including rash and alopecia.","section":"What the evidence actually shows","tier":"human","source_ids":["web:16","web:10"],"source_status":"sourced","why_material":"Documents real-world skin reaction frequency from human reports.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Rapid weight loss from tirzepatide is associated with loose skin due to loss of subcutaneous fat support.","section":"What's breaking down","tier":"human","source_ids":["web:11","web:13"],"source_status":"sourced","why_material":"Links weight-loss mechanism to skin laxity in human observational contexts.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 3 trials are testing tirzepatide for psoriasis and psoriatic arthritis.","section":"What the evidence actually shows","tier":"human","source_ids":["web:14"],"source_status":"sourced","why_material":"Indicates active human investigation into inflammatory skin benefits.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"User reports on Reddit describe both loose skin and occasional improvement in acne or eczema after tirzepatide.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:0","web:5"],"source_status":"sourced","why_material":"Captures patient-experience patterns separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Weight loss reduces mechanical support from fat, leading to decreased skin firmness via collagen changes.","section":"What's breaking down","tier":"mechanistic","source_ids":["web:13"],"source_status":"sourced","why_material":"Explains physiological pathway without claiming clinical outcome.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:10","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12800350/","title":"Tirzepatide in dermatology: cutaneous adverse events...","quote":"the most reported adverse reaction was eczematous reactions (183 cases), followed by alopecia","summary":"Review of cutaneous events and potential therapeutic roles.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"77bc1c5b1ba076643d5f4867fb4c79f9cbae68dc9a1ee5bf98046dd2d6998aa1"},{"id":"web:11","type":"news","url":"https://www.philadelphialiposuction.com/surgery/loose-skin-after-tirzepatide-causes-prevention-and-cosmetic-options/","title":"Loose Skin After Tirzepatide","quote":"dramatic weight loss... can result in loose skin","summary":"Discusses loose skin risk after tirzepatide weight loss.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"77bc1c5b1ba076643d5f4867fb4c79f9cbae68dc9a1ee5bf98046dd2d6998aa1","hash":"860ff568fcc2bb0ac4b1293bcc428d027d2f946b6a2768f306a1027989ec5c59"},{"id":"web:14","type":"news","url":"https://www.medscape.com/viewarticle/weight-loss-drugs-show-increasing-benefit-skin-disease-2025a1000box","title":"Weight-Loss Drugs Show Increasing Benefit in Skin Disease","quote":"Eli Lilly... conducting two Phase 3 trials, TOGETHER-PsO and TOGETHER-PsA","summary":"Reports ongoing psoriasis trials for tirzepatide.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"860ff568fcc2bb0ac4b1293bcc428d027d2f946b6a2768f306a1027989ec5c59","hash":"be311e7ecda9cf1c19c84932d4263d4d900ef962400eb48e600b48fd985b7ce1"},{"id":"web:16","type":"pubmed","url":"https://jddonline.com/articles/cross-sectional-analysis-of-adverse-dermatologic-events-reported-fda-after-use-of-glp-1-agonists-S1545961624P8287X","title":"Cross-Sectional Analysis of Adverse Dermatologic Events...","quote":"4,896 (6.08%) were dermatologic... top reported reactions were rash, pruritus, alopecia","summary":"FAERS analysis of skin adverse events with GLP-1s.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"be311e7ecda9cf1c19c84932d4263d4d900ef962400eb48e600b48fd985b7ce1","hash":"7c9f9f2061445c4960809b1047036f2bf9ce56b9cbbfac77e78cf42565f77402"},{"id":"web:0","type":"reddit","url":"https://www.reddit.com/r/GLPGrad/comments/1qfnyyh/i_have_been_on_tirzepatide_about_8_months_and/","title":"my body has aged 20 years. Loose skin...","quote":"Loose skin, wrinkling, muscle loss","summary":"User reports loose skin after tirzepatide.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"7c9f9f2061445c4960809b1047036f2bf9ce56b9cbbfac77e78cf42565f77402","hash":"146ad47ef1ccf624655d83c27fa066d21cf2f36fc1e923a27b0afabb9f9c78b6"},{"id":"web:5","type":"reddit","url":"https://www.reddit.com/r/antidietglp1/comments/1r46oc9/tirzepatide_has_cleared_my_cystic_acne/","title":"Tirzepatide Has Cleared My Cystic Acne!","quote":"my skin has cleared up dramatically","summary":"User reports acne improvement.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"146ad47ef1ccf624655d83c27fa066d21cf2f36fc1e923a27b0afabb9f9c78b6","hash":"820abf3cb9b3cc32d98ad22257c22d05e1dda86461748a17fa8d4bce95d0b77e"},{"id":"web:13","type":"pubmed","url":"https://www.scielo.br/j/abd/a/dXD9vGCV3ZZMdF5NjrFCh6G/?format=pdf&lang=en","title":"Tirzepatide in dermatology","quote":"loss of mechanical support provided by fat... reduced skin firmness and increased laxity","summary":"Mechanistic explanation of skin changes post-weight loss.","claim_ids":["c3","c6"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"820abf3cb9b3cc32d98ad22257c22d05e1dda86461748a17fa8d4bce95d0b77e","hash":"abb390b42f3ededdab9102fccdb71d59cb8aedcbe0dc9926ae6805ca63d2eb28"},{"id":"web:24","type":"news","url":"https://www.prnewswire.com/news-releases/tirzepatide-demonstrated-significant-and-superior-weight-loss-compared-to-placebo-in-two-pivotal-studies-301887287.html","title":"Tirzepatide weight loss studies","quote":"additional 21.1% mean weight loss","summary":"Reports magnitude of weight reduction.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"verified","prev":"abb390b42f3ededdab9102fccdb71d59cb8aedcbe0dc9926ae6805ca63d2eb28","hash":"bc1fd3172005a1d0e051f5aea9940ebcbccc7bc456d92fa5fb77fc9519a62cd8"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:39:02.380Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions","register":"source_ledger","body":"## What's breaking down\n\nSkin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that does not retract fully. Inflammatory skin diseases such as psoriasis or hidradenitis suppurativa can worsen with metabolic stress and excess weight. These processes reflect degeneration outpacing the skin's ability to maintain firmness and barrier function. Tirzepatide targets body weight and glucose control; any skin discussion centers on whether those changes support or challenge skin integrity.\n\n## Why Tirzepatide might help you\n\n1. What keeps failing: Excess body weight maintains mechanical stretch on skin while metabolic factors sustain low-grade inflammation that impairs collagen maintenance.\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP pathways linked to substantial weight reduction (typically 15-20% body weight in trials) and improved glycemic control.\n3. Therefore for you: If excess weight or related inflammation forms part of the skin issue, Tirzepatide is examined because it addresses the metabolic load layer through fat reduction rather than directly altering skin cells or masking symptoms.\n\nWeight loss of this magnitude decreases compressive forces on tissues overall. For skin specifically, less subcutaneous fat can reveal or accentuate laxity in areas previously supported by adipose tissue. The same pathway may lower systemic inflammation that contributes to certain dermatologic conditions.\n\n## How these fit together\n\nSingle-compound focus. Tirzepatide acts on the metabolic load and body weight layer. Any skin outcome—whether reduced inflammatory drive in conditions like psoriasis or increased laxity from rapid fat loss—stems from that primary action. No sibling compounds appear in scope to address separate layers such as direct collagen synthesis or sleep-mediated repair.\n\n## What the evidence actually shows\n\nHuman trial data from SURPASS and SURMOUNT programs demonstrate consistent weight loss but do not report primary skin repair endpoints. FAERS pharmacovigilance analysis of GLP-1 agonists (including tirzepatide) recorded dermatologic events in roughly 6% of reports, with rash, pruritus, and alopecia among the most frequent. A 2025 narrative review in Anais Brasileiros de Dermatologia summarized cutaneous adverse events and noted emerging case reports for hidradenitis suppurativa improvement. Phase 3 trials TOGETHER-PsO and TOGETHER-PsA are underway for psoriasis and psoriatic arthritis; results expected 2026. No large randomized human trials yet confirm direct collagen or elasticity gains from tirzepatide. Preclinical and mechanistic observations link rapid weight loss to altered collagen fiber ratios and reduced skin firmness due to loss of fat padding. Reddit threads describe loose skin, facial volume changes, occasional acne clearance, and transient burning sensations. X posts echo similar anecdotal patterns of sagging or improved inflammatory skin appearance, though volume remains limited. Evidence inventory: multiple human weight-loss trials and FAERS reports (human tier), case series and ongoing trials (human tier), mechanistic descriptions of fat loss effects (mechanistic tier), user reports (anecdotal tier). No rat skin-specific tirzepatide studies identified in searches.\n\n## What scientists say\n\nReviews note that tirzepatide-induced weight loss can produce aesthetic skin changes secondary to volume reduction, similar to post-bariatric outcomes. Immunomodulatory effects via GLP-1 signaling are hypothesized to benefit inflammatory dermatoses, but data stay preliminary. Experts emphasize that skin adaptation lags behind fat loss, particularly after age 40 or with long-standing obesity. Ongoing trials will clarify whether metabolic improvement translates to measurable skin clearance beyond weight effects.\n\n## What people say on Reddit\n\nUsers report loose or sagging skin after significant loss, sometimes describing an aged appearance in face and body. Some note clearing of cystic acne or eczema-like symptoms. Injection-site reactions, allodynia, and transient burning sensations appear in multiple threads. Others mention hair shedding or facial hollowing. Positive skin stories often tie to overall health gains rather than direct dermatologic action. Experiences vary widely by dose, duration, age, and prior skin condition.\n\n## What people say on X\n\nPosts reference \"Ozempic face\" or Zepbound-related sagging, with some users celebrating reduced inflammation in psoriasis or HS. Complaints center on unexpected laxity despite health improvements. Anecdotes about clearer skin or new sensitivities circulate but lack systematic tracking. Volume of skin-specific discussion remains lower than general weight-loss threads.\n\n## What we do not know\n\nLong-term effects on skin elasticity and collagen remodeling after sustained tirzepatide use remain unquantified in large human cohorts. Whether benefits in inflammatory skin disease stem from weight loss, direct receptor action, or both is unresolved. Optimal strategies to support skin during rapid loss (nutrition, resistance training, topical care) lack dedicated tirzepatide trials. Differential impact by age, sex, duration of obesity, and genetics is not delineated.\n\n## Safety and limits\n\nCommon cutaneous reports include injection-site reactions and generalized rashes. Alopecia and pruritus appear in pharmacovigilance data. Rapid weight loss itself carries risk of visible laxity regardless of method. Tirzepatide is not indicated or studied as a primary skin treatment. All observations require individual medical evaluation; no dosing or therapeutic recommendations are implied.\n","claims":[{"id":"c1","text":"Tirzepatide produces 15-20% body weight reduction in clinical trials.","section":"Why Tirzepatide might help you","tier":"human","source_ids":["web:24"],"source_status":"sourced","why_material":"Establishes magnitude of weight change that can affect skin support.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"FAERS data show dermatologic adverse events in ~6% of GLP-1 agonist reports, including rash and alopecia.","section":"What the evidence actually shows","tier":"human","source_ids":["web:16"],"source_status":"sourced","why_material":"Documents real-world skin reaction frequency from human reports.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Rapid weight loss from tirzepatide is associated with loose skin due to loss of subcutaneous fat support.","section":"What's breaking down","tier":"human","source_ids":["web:11","web:13"],"source_status":"sourced","why_material":"Links weight-loss mechanism to skin laxity in human observational contexts.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 3 trials are testing tirzepatide for psoriasis and psoriatic arthritis.","section":"What the evidence actually shows","tier":"human","source_ids":["web:14"],"source_status":"sourced","why_material":"Indicates active human investigation into inflammatory skin benefits.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"User reports on Reddit describe both loose skin and occasional improvement in acne or eczema after tirzepatide.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:0","web:5"],"source_status":"sourced","why_material":"Captures patient-experience patterns separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Weight loss reduces mechanical support from fat, leading to decreased skin firmness via collagen changes.","section":"What's breaking down","tier":"mechanistic","source_ids":["web:13"],"source_status":"sourced","why_material":"Explains physiological pathway without claiming clinical outcome.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:10","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12800350/","title":"Tirzepatide in dermatology: cutaneous adverse events...","quote":"the most reported adverse reaction was eczematous reactions (183 cases), followed by alopecia","link_status":"ok","quote_status":"verified"},{"id":"web:11","type":"news","url":"https://www.philadelphialiposuction.com/surgery/loose-skin-after-tirzepatide-causes-prevention-and-cosmetic-options/","title":"Loose Skin After Tirzepatide","quote":"dramatic weight loss... can result in loose skin","link_status":"ok","quote_status":"unverified"},{"id":"web:14","type":"news","url":"https://www.medscape.com/viewarticle/weight-loss-drugs-show-increasing-benefit-skin-disease-2025a1000box","title":"Weight-Loss Drugs Show Increasing Benefit in Skin Disease","quote":"Eli Lilly... conducting two Phase 3 trials, TOGETHER-PsO and TOGETHER-PsA","link_status":"ok","quote_status":"unverified"},{"id":"web:16","type":"pubmed","url":"https://jddonline.com/articles/cross-sectional-analysis-of-adverse-dermatologic-events-reported-fda-after-use-of-glp-1-agonists-S1545961624P8287X","title":"Cross-Sectional Analysis of Adverse Dermatologic Events...","quote":"4,896 (6.08%) were dermatologic... top reported reactions were rash, pruritus, alopecia","link_status":"ok","quote_status":"unverified"},{"id":"web:0","type":"reddit","url":"https://www.reddit.com/r/GLPGrad/comments/1qfnyyh/i_have_been_on_tirzepatide_about_8_months_and/","title":"my body has aged 20 years. Loose skin...","quote":"Loose skin, wrinkling, muscle loss","link_status":"ok","quote_status":"unverified"},{"id":"web:5","type":"reddit","url":"https://www.reddit.com/r/antidietglp1/comments/1r46oc9/tirzepatide_has_cleared_my_cystic_acne/","title":"Tirzepatide Has Cleared My Cystic Acne!","quote":"my skin has cleared up dramatically","link_status":"ok","quote_status":"unverified"},{"id":"web:13","type":"pubmed","url":"https://www.scielo.br/j/abd/a/dXD9vGCV3ZZMdF5NjrFCh6G/?format=pdf&lang=en","title":"Tirzepatide in dermatology","quote":"loss of mechanical support provided by fat... reduced skin firmness and increased laxity","link_status":"ok","quote_status":"unverified"},{"id":"web:24","type":"news","url":"https://www.prnewswire.com/news-releases/tirzepatide-demonstrated-significant-and-superior-weight-loss-compared-to-placebo-in-two-pivotal-studies-301887287.html","title":"Tirzepatide weight loss studies","quote":"additional 21.1% mean weight loss","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":17476,"tokens_out":4066,"cost":0.03201,"prev_hash":"genesis","hash":"f9ccf1248479de6d353001f27a9ae158488558434d13e504d9585f4cb83f0d19"}],"provenance":[{"ts":"2026-06-29T22:39:02.380Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Skin\nSlug: tirzepatide-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile incl","response":"{\n  \"slug\": \"tirzepatide-skin\",\n  \"title\": \"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions\",\n  \"body\": \"## What's breaking down\\n\\nSkin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that does not retract fully. Inflammatory skin diseases such as psoriasis or hidradenitis suppurativa can worsen with metabolic stress and excess weight. These processes reflect degeneration outpacing the skin's ability to maintain firmness and barrier function. Tirzepatide targets body weight and glucose control; any skin discussion centers on whether those changes support or challenge skin integrity.\\n\\n## Why Tirzepatide might help you\\n\\n1. What keeps failing: Excess body weight maintains mechanical stretch on skin while metabolic factors sustain low-grade inflammation that impairs collagen maintenance.\\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP pathways linked to substantial weight reduction (typically 15-20% body weight in trials) and improved glycemic control.\\n3. Therefore for you: If excess weight or related inflammation forms part of the skin issue, Tirzepatide is examined because it addresses the metabolic load layer through fat reduction rather than directly altering skin cells or masking symptoms.\\n\\nWeight loss of this magnitude decreases compressive forces on tissues overall. For skin specifically, less subcutaneous fat can reveal or accentuate laxity in areas previously supported by adipose tissue. The same pathway may lower systemic inflammation that contributes to certain dermatologic conditions.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tirzepatide acts on the metabolic load and body weight layer. Any skin outcome—whether reduced inflammatory drive in conditions like psoriasis or increased laxity from rapid fat loss—stem","tokens_in":17476,"tokens_out":4066,"cost":0,"prev":"genesis","hash":"fa87b8ee6567bf33ed27812eded36383c200caffafc63d3fff5270100f33ce77"},{"ts":"2026-07-17T02:43:19.771Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-skin","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fa87b8ee6567bf33ed27812eded36383c200caffafc63d3fff5270100f33ce77","hash":"90c1b565e630d532f66eade36b1d0808d5091e38e4c090609c44196b28a7715e"}],"energy":{"passes":2,"tokens_in":17476,"tokens_out":4066,"tokens_total":21542,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"90c1b565e630d532f66eade36b1d0808d5091e38e4c090609c44196b28a7715e"},"posted_at":"2026-06-29T21:33:47.310Z","created_at":"2026-06-29T21:33:47.310Z","updated_at":"2026-07-17T02:43:19.771Z","machine":{"shape":"article.machine/v1","slug":"tirzepatide-skin","kind":"article","read":{"human":"https://miscsubjects.com/a/tirzepatide-skin","json":"https://miscsubjects.com/api/articles/tirzepatide-skin","bundle":"https://miscsubjects.com/api/articles/tirzepatide-skin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":6,"sources":8,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tirzepatide-skin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tirzepatide-skin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tirzepatide-skin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tirzepatide-skin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tirzepatide-skin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tirzepatide-skin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tirzepatide-skin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tirzepatide-skin","json":"/api/articles/tirzepatide-skin","markdown":"/api/articles/tirzepatide-skin/bundle?format=markdown","skill":"/api/articles/tirzepatide-skin/skill","topology":"/api/articles/tirzepatide-skin/topology","versions":"/api/articles/tirzepatide-skin/revisions","invocations":"/api/articles/tirzepatide-skin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tirzepatide-skin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"052d9d89474c1468de33d3a2ee713e17face412cc174f3ca6c74f186092e8150","object":{"object_type":"article-object","identity":{"id":"article:tirzepatide-skin","slug":"tirzepatide-skin","title":"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/tirzepatide-skin","role":"explain","audience":"human"},"skill":{"route":"/api/articles/tirzepatide-skin/skill","role":"direct behavior","audience":"model","content":"---\nname: tirzepatide-skin\ndescription: Apply the Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions\n\nThis Skill is the behavioral expression of [the canonical article](/a/tirzepatide-skin). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/tirzepatide-skin.\n- Read claims and relationships at /api/articles/tirzepatide-skin/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Skin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that d\n\n## Representations\n\n- Human: /a/tirzepatide-skin\n- JSON: /api/articles/tirzepatide-skin\n- Relationships: /api/articles/tirzepatide-skin/topology\n- History: /api/articles/tirzepatide-skin/revisions\n"},"json":{"route":"/api/articles/tirzepatide-skin","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/tirzepatide-skin/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","tirzepatide","skin"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/tirzepatide-skin/invocations?status=success","failure_events":"/api/articles/tirzepatide-skin/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"tirzepatide-skin","title":"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions","body":"## What's breaking down\n\nSkin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that does not retract fully. Inflammatory skin diseases such as psoriasis or hidradenitis suppurativa can worsen with metabolic stress and excess weight. These processes reflect degeneration outpacing the skin's ability to maintain firmness and barrier function. Tirzepatide targets body weight and glucose control; any skin discussion centers on whether those changes support or challenge skin integrity.\n\n## Why Tirzepatide might help you\n\n1. What keeps failing: Excess body weight maintains mechanical stretch on skin while metabolic factors sustain low-grade inflammation that impairs collagen maintenance.\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP pathways linked to substantial weight reduction (typically 15-20% body weight in trials) and improved glycemic control.\n3. Therefore for you: If excess weight or related inflammation forms part of the skin issue, Tirzepatide is examined because it addresses the metabolic load layer through fat reduction rather than directly altering skin cells or masking symptoms.\n\nWeight loss of this magnitude decreases compressive forces on tissues overall. For skin specifically, less subcutaneous fat can reveal or accentuate laxity in areas previously supported by adipose tissue. The same pathway may lower systemic inflammation that contributes to certain dermatologic conditions.\n\n## How these fit together\n\nSingle-compound focus. Tirzepatide acts on the metabolic load and body weight layer. Any skin outcome—whether reduced inflammatory drive in conditions like psoriasis or increased laxity from rapid fat loss—stems from that primary action. No sibling compounds appear in scope to address separate layers such as direct collagen synthesis or sleep-mediated repair.\n\n## What the evidence actually shows\n\nHuman trial data from SURPASS and SURMOUNT programs demonstrate consistent weight loss but do not report primary skin repair endpoints. FAERS pharmacovigilance analysis of GLP-1 agonists (including tirzepatide) recorded dermatologic events in roughly 6% of reports, with rash, pruritus, and alopecia among the most frequent. A 2025 narrative review in Anais Brasileiros de Dermatologia summarized cutaneous adverse events and noted emerging case reports for hidradenitis suppurativa improvement. Phase 3 trials TOGETHER-PsO and TOGETHER-PsA are underway for psoriasis and psoriatic arthritis; results expected 2026. No large randomized human trials yet confirm direct collagen or elasticity gains from tirzepatide. Preclinical and mechanistic observations link rapid weight loss to altered collagen fiber ratios and reduced skin firmness due to loss of fat padding. Reddit threads describe loose skin, facial volume changes, occasional acne clearance, and transient burning sensations. X posts echo similar anecdotal patterns of sagging or improved inflammatory skin appearance, though volume remains limited. Evidence inventory: multiple human weight-loss trials and FAERS reports (human tier), case series and ongoing trials (human tier), mechanistic descriptions of fat loss effects (mechanistic tier), user reports (anecdotal tier). No rat skin-specific tirzepatide studies identified in searches.\n\n## What scientists say\n\nReviews note that tirzepatide-induced weight loss can produce aesthetic skin changes secondary to volume reduction, similar to post-bariatric outcomes. Immunomodulatory effects via GLP-1 signaling are hypothesized to benefit inflammatory dermatoses, but data stay preliminary. Experts emphasize that skin adaptation lags behind fat loss, particularly after age 40 or with long-standing obesity. Ongoing trials will clarify whether metabolic improvement translates to measurable skin clearance beyond weight effects.\n\n## What people say on Reddit\n\nUsers report loose or sagging skin after significant loss, sometimes describing an aged appearance in face and body. Some note clearing of cystic acne or eczema-like symptoms. Injection-site reactions, allodynia, and transient burning sensations appear in multiple threads. Others mention hair shedding or facial hollowing. Positive skin stories often tie to overall health gains rather than direct dermatologic action. Experiences vary widely by dose, duration, age, and prior skin condition.\n\n## What people say on X\n\nPosts reference \"Ozempic face\" or Zepbound-related sagging, with some users celebrating reduced inflammation in psoriasis or HS. Complaints center on unexpected laxity despite health improvements. Anecdotes about clearer skin or new sensitivities circulate but lack systematic tracking. Volume of skin-specific discussion remains lower than general weight-loss threads.\n\n## What we do not know\n\nLong-term effects on skin elasticity and collagen remodeling after sustained tirzepatide use remain unquantified in large human cohorts. Whether benefits in inflammatory skin disease stem from weight loss, direct receptor action, or both is unresolved. Optimal strategies to support skin during rapid loss (nutrition, resistance training, topical care) lack dedicated tirzepatide trials. Differential impact by age, sex, duration of obesity, and genetics is not delineated.\n\n## Safety and limits\n\nCommon cutaneous reports include injection-site reactions and generalized rashes. Alopecia and pruritus appear in pharmacovigilance data. Rapid weight loss itself carries risk of visible laxity regardless of method. Tirzepatide is not indicated or studied as a primary skin treatment. All observations require individual medical evaluation; no dosing or therapeutic recommendations are implied.\n","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tirzepatide-skin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Tirzepatide produces 15-20% body weight reduction in clinical trials.","section":"Why Tirzepatide might help you","tier":"human","source_ids":["web:24"],"source_status":"sourced","why_material":"Establishes magnitude of weight change that can affect skin support.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"FAERS data show dermatologic adverse events in ~6% of GLP-1 agonist reports, including rash and alopecia.","section":"What the evidence actually shows","tier":"human","source_ids":["web:16","web:10"],"source_status":"sourced","why_material":"Documents real-world skin reaction frequency from human reports.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Rapid weight loss from tirzepatide is associated with loose skin due to loss of subcutaneous fat support.","section":"What's breaking down","tier":"human","source_ids":["web:11","web:13"],"source_status":"sourced","why_material":"Links weight-loss mechanism to skin laxity in human observational contexts.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 3 trials are testing tirzepatide for psoriasis and psoriatic arthritis.","section":"What the evidence actually shows","tier":"human","source_ids":["web:14"],"source_status":"sourced","why_material":"Indicates active human investigation into inflammatory skin benefits.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"User reports on Reddit describe both loose skin and occasional improvement in acne or eczema after tirzepatide.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:0","web:5"],"source_status":"sourced","why_material":"Captures patient-experience patterns separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Weight loss reduces mechanical support from fat, leading to decreased skin firmness via collagen changes.","section":"What's breaking down","tier":"mechanistic","source_ids":["web:13"],"source_status":"sourced","why_material":"Explains physiological pathway without claiming clinical outcome.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:10","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12800350/","title":"Tirzepatide in dermatology: cutaneous adverse events...","quote":"the most reported adverse reaction was eczematous reactions (183 cases), followed by alopecia","summary":"Review of cutaneous events and potential therapeutic roles.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"77bc1c5b1ba076643d5f4867fb4c79f9cbae68dc9a1ee5bf98046dd2d6998aa1"},{"id":"web:11","type":"news","url":"https://www.philadelphialiposuction.com/surgery/loose-skin-after-tirzepatide-causes-prevention-and-cosmetic-options/","title":"Loose Skin After Tirzepatide","quote":"dramatic weight loss... can result in loose skin","summary":"Discusses loose skin risk after tirzepatide weight loss.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"77bc1c5b1ba076643d5f4867fb4c79f9cbae68dc9a1ee5bf98046dd2d6998aa1","hash":"860ff568fcc2bb0ac4b1293bcc428d027d2f946b6a2768f306a1027989ec5c59"},{"id":"web:14","type":"news","url":"https://www.medscape.com/viewarticle/weight-loss-drugs-show-increasing-benefit-skin-disease-2025a1000box","title":"Weight-Loss Drugs Show Increasing Benefit in Skin Disease","quote":"Eli Lilly... conducting two Phase 3 trials, TOGETHER-PsO and TOGETHER-PsA","summary":"Reports ongoing psoriasis trials for tirzepatide.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"860ff568fcc2bb0ac4b1293bcc428d027d2f946b6a2768f306a1027989ec5c59","hash":"be311e7ecda9cf1c19c84932d4263d4d900ef962400eb48e600b48fd985b7ce1"},{"id":"web:16","type":"pubmed","url":"https://jddonline.com/articles/cross-sectional-analysis-of-adverse-dermatologic-events-reported-fda-after-use-of-glp-1-agonists-S1545961624P8287X","title":"Cross-Sectional Analysis of Adverse Dermatologic Events...","quote":"4,896 (6.08%) were dermatologic... top reported reactions were rash, pruritus, alopecia","summary":"FAERS analysis of skin adverse events with GLP-1s.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"be311e7ecda9cf1c19c84932d4263d4d900ef962400eb48e600b48fd985b7ce1","hash":"7c9f9f2061445c4960809b1047036f2bf9ce56b9cbbfac77e78cf42565f77402"},{"id":"web:0","type":"reddit","url":"https://www.reddit.com/r/GLPGrad/comments/1qfnyyh/i_have_been_on_tirzepatide_about_8_months_and/","title":"my body has aged 20 years. Loose skin...","quote":"Loose skin, wrinkling, muscle loss","summary":"User reports loose skin after tirzepatide.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"7c9f9f2061445c4960809b1047036f2bf9ce56b9cbbfac77e78cf42565f77402","hash":"146ad47ef1ccf624655d83c27fa066d21cf2f36fc1e923a27b0afabb9f9c78b6"},{"id":"web:5","type":"reddit","url":"https://www.reddit.com/r/antidietglp1/comments/1r46oc9/tirzepatide_has_cleared_my_cystic_acne/","title":"Tirzepatide Has Cleared My Cystic Acne!","quote":"my skin has cleared up dramatically","summary":"User reports acne improvement.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"146ad47ef1ccf624655d83c27fa066d21cf2f36fc1e923a27b0afabb9f9c78b6","hash":"820abf3cb9b3cc32d98ad22257c22d05e1dda86461748a17fa8d4bce95d0b77e"},{"id":"web:13","type":"pubmed","url":"https://www.scielo.br/j/abd/a/dXD9vGCV3ZZMdF5NjrFCh6G/?format=pdf&lang=en","title":"Tirzepatide in dermatology","quote":"loss of mechanical support provided by fat... reduced skin firmness and increased laxity","summary":"Mechanistic explanation of skin changes post-weight loss.","claim_ids":["c3","c6"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"unverified","prev":"820abf3cb9b3cc32d98ad22257c22d05e1dda86461748a17fa8d4bce95d0b77e","hash":"abb390b42f3ededdab9102fccdb71d59cb8aedcbe0dc9926ae6805ca63d2eb28"},{"id":"web:24","type":"news","url":"https://www.prnewswire.com/news-releases/tirzepatide-demonstrated-significant-and-superior-weight-loss-compared-to-placebo-in-two-pivotal-studies-301887287.html","title":"Tirzepatide weight loss studies","quote":"additional 21.1% mean weight loss","summary":"Reports magnitude of weight reduction.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:38:59.097Z","link_status":"ok","quote_status":"verified","prev":"abb390b42f3ededdab9102fccdb71d59cb8aedcbe0dc9926ae6805ca63d2eb28","hash":"bc1fd3172005a1d0e051f5aea9940ebcbccc7bc456d92fa5fb77fc9519a62cd8"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:39:02.380Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions","register":"source_ledger","body":"## What's breaking down\n\nSkin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that does not retract fully. Inflammatory skin diseases such as psoriasis or hidradenitis suppurativa can worsen with metabolic stress and excess weight. These processes reflect degeneration outpacing the skin's ability to maintain firmness and barrier function. Tirzepatide targets body weight and glucose control; any skin discussion centers on whether those changes support or challenge skin integrity.\n\n## Why Tirzepatide might help you\n\n1. What keeps failing: Excess body weight maintains mechanical stretch on skin while metabolic factors sustain low-grade inflammation that impairs collagen maintenance.\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP pathways linked to substantial weight reduction (typically 15-20% body weight in trials) and improved glycemic control.\n3. Therefore for you: If excess weight or related inflammation forms part of the skin issue, Tirzepatide is examined because it addresses the metabolic load layer through fat reduction rather than directly altering skin cells or masking symptoms.\n\nWeight loss of this magnitude decreases compressive forces on tissues overall. For skin specifically, less subcutaneous fat can reveal or accentuate laxity in areas previously supported by adipose tissue. The same pathway may lower systemic inflammation that contributes to certain dermatologic conditions.\n\n## How these fit together\n\nSingle-compound focus. Tirzepatide acts on the metabolic load and body weight layer. Any skin outcome—whether reduced inflammatory drive in conditions like psoriasis or increased laxity from rapid fat loss—stems from that primary action. No sibling compounds appear in scope to address separate layers such as direct collagen synthesis or sleep-mediated repair.\n\n## What the evidence actually shows\n\nHuman trial data from SURPASS and SURMOUNT programs demonstrate consistent weight loss but do not report primary skin repair endpoints. FAERS pharmacovigilance analysis of GLP-1 agonists (including tirzepatide) recorded dermatologic events in roughly 6% of reports, with rash, pruritus, and alopecia among the most frequent. A 2025 narrative review in Anais Brasileiros de Dermatologia summarized cutaneous adverse events and noted emerging case reports for hidradenitis suppurativa improvement. Phase 3 trials TOGETHER-PsO and TOGETHER-PsA are underway for psoriasis and psoriatic arthritis; results expected 2026. No large randomized human trials yet confirm direct collagen or elasticity gains from tirzepatide. Preclinical and mechanistic observations link rapid weight loss to altered collagen fiber ratios and reduced skin firmness due to loss of fat padding. Reddit threads describe loose skin, facial volume changes, occasional acne clearance, and transient burning sensations. X posts echo similar anecdotal patterns of sagging or improved inflammatory skin appearance, though volume remains limited. Evidence inventory: multiple human weight-loss trials and FAERS reports (human tier), case series and ongoing trials (human tier), mechanistic descriptions of fat loss effects (mechanistic tier), user reports (anecdotal tier). No rat skin-specific tirzepatide studies identified in searches.\n\n## What scientists say\n\nReviews note that tirzepatide-induced weight loss can produce aesthetic skin changes secondary to volume reduction, similar to post-bariatric outcomes. Immunomodulatory effects via GLP-1 signaling are hypothesized to benefit inflammatory dermatoses, but data stay preliminary. Experts emphasize that skin adaptation lags behind fat loss, particularly after age 40 or with long-standing obesity. Ongoing trials will clarify whether metabolic improvement translates to measurable skin clearance beyond weight effects.\n\n## What people say on Reddit\n\nUsers report loose or sagging skin after significant loss, sometimes describing an aged appearance in face and body. Some note clearing of cystic acne or eczema-like symptoms. Injection-site reactions, allodynia, and transient burning sensations appear in multiple threads. Others mention hair shedding or facial hollowing. Positive skin stories often tie to overall health gains rather than direct dermatologic action. Experiences vary widely by dose, duration, age, and prior skin condition.\n\n## What people say on X\n\nPosts reference \"Ozempic face\" or Zepbound-related sagging, with some users celebrating reduced inflammation in psoriasis or HS. Complaints center on unexpected laxity despite health improvements. Anecdotes about clearer skin or new sensitivities circulate but lack systematic tracking. Volume of skin-specific discussion remains lower than general weight-loss threads.\n\n## What we do not know\n\nLong-term effects on skin elasticity and collagen remodeling after sustained tirzepatide use remain unquantified in large human cohorts. Whether benefits in inflammatory skin disease stem from weight loss, direct receptor action, or both is unresolved. Optimal strategies to support skin during rapid loss (nutrition, resistance training, topical care) lack dedicated tirzepatide trials. Differential impact by age, sex, duration of obesity, and genetics is not delineated.\n\n## Safety and limits\n\nCommon cutaneous reports include injection-site reactions and generalized rashes. Alopecia and pruritus appear in pharmacovigilance data. Rapid weight loss itself carries risk of visible laxity regardless of method. Tirzepatide is not indicated or studied as a primary skin treatment. All observations require individual medical evaluation; no dosing or therapeutic recommendations are implied.\n","claims":[{"id":"c1","text":"Tirzepatide produces 15-20% body weight reduction in clinical trials.","section":"Why Tirzepatide might help you","tier":"human","source_ids":["web:24"],"source_status":"sourced","why_material":"Establishes magnitude of weight change that can affect skin support.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"FAERS data show dermatologic adverse events in ~6% of GLP-1 agonist reports, including rash and alopecia.","section":"What the evidence actually shows","tier":"human","source_ids":["web:16"],"source_status":"sourced","why_material":"Documents real-world skin reaction frequency from human reports.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Rapid weight loss from tirzepatide is associated with loose skin due to loss of subcutaneous fat support.","section":"What's breaking down","tier":"human","source_ids":["web:11","web:13"],"source_status":"sourced","why_material":"Links weight-loss mechanism to skin laxity in human observational contexts.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 3 trials are testing tirzepatide for psoriasis and psoriatic arthritis.","section":"What the evidence actually shows","tier":"human","source_ids":["web:14"],"source_status":"sourced","why_material":"Indicates active human investigation into inflammatory skin benefits.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"User reports on Reddit describe both loose skin and occasional improvement in acne or eczema after tirzepatide.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:0","web:5"],"source_status":"sourced","why_material":"Captures patient-experience patterns separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Weight loss reduces mechanical support from fat, leading to decreased skin firmness via collagen changes.","section":"What's breaking down","tier":"mechanistic","source_ids":["web:13"],"source_status":"sourced","why_material":"Explains physiological pathway without claiming clinical outcome.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:38:59.939Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:10","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12800350/","title":"Tirzepatide in dermatology: cutaneous adverse events...","quote":"the most reported adverse reaction was eczematous reactions (183 cases), followed by alopecia","link_status":"ok","quote_status":"verified"},{"id":"web:11","type":"news","url":"https://www.philadelphialiposuction.com/surgery/loose-skin-after-tirzepatide-causes-prevention-and-cosmetic-options/","title":"Loose Skin After Tirzepatide","quote":"dramatic weight loss... can result in loose skin","link_status":"ok","quote_status":"unverified"},{"id":"web:14","type":"news","url":"https://www.medscape.com/viewarticle/weight-loss-drugs-show-increasing-benefit-skin-disease-2025a1000box","title":"Weight-Loss Drugs Show Increasing Benefit in Skin Disease","quote":"Eli Lilly... conducting two Phase 3 trials, TOGETHER-PsO and TOGETHER-PsA","link_status":"ok","quote_status":"unverified"},{"id":"web:16","type":"pubmed","url":"https://jddonline.com/articles/cross-sectional-analysis-of-adverse-dermatologic-events-reported-fda-after-use-of-glp-1-agonists-S1545961624P8287X","title":"Cross-Sectional Analysis of Adverse Dermatologic Events...","quote":"4,896 (6.08%) were dermatologic... top reported reactions were rash, pruritus, alopecia","link_status":"ok","quote_status":"unverified"},{"id":"web:0","type":"reddit","url":"https://www.reddit.com/r/GLPGrad/comments/1qfnyyh/i_have_been_on_tirzepatide_about_8_months_and/","title":"my body has aged 20 years. Loose skin...","quote":"Loose skin, wrinkling, muscle loss","link_status":"ok","quote_status":"unverified"},{"id":"web:5","type":"reddit","url":"https://www.reddit.com/r/antidietglp1/comments/1r46oc9/tirzepatide_has_cleared_my_cystic_acne/","title":"Tirzepatide Has Cleared My Cystic Acne!","quote":"my skin has cleared up dramatically","link_status":"ok","quote_status":"unverified"},{"id":"web:13","type":"pubmed","url":"https://www.scielo.br/j/abd/a/dXD9vGCV3ZZMdF5NjrFCh6G/?format=pdf&lang=en","title":"Tirzepatide in dermatology","quote":"loss of mechanical support provided by fat... reduced skin firmness and increased laxity","link_status":"ok","quote_status":"unverified"},{"id":"web:24","type":"news","url":"https://www.prnewswire.com/news-releases/tirzepatide-demonstrated-significant-and-superior-weight-loss-compared-to-placebo-in-two-pivotal-studies-301887287.html","title":"Tirzepatide weight loss studies","quote":"additional 21.1% mean weight loss","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":17476,"tokens_out":4066,"cost":0.03201,"prev_hash":"genesis","hash":"f9ccf1248479de6d353001f27a9ae158488558434d13e504d9585f4cb83f0d19"}],"provenance":[{"ts":"2026-06-29T22:39:02.380Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Skin\nSlug: tirzepatide-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile incl","response":"{\n  \"slug\": \"tirzepatide-skin\",\n  \"title\": \"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions\",\n  \"body\": \"## What's breaking down\\n\\nSkin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that does not retract fully. Inflammatory skin diseases such as psoriasis or hidradenitis suppurativa can worsen with metabolic stress and excess weight. These processes reflect degeneration outpacing the skin's ability to maintain firmness and barrier function. Tirzepatide targets body weight and glucose control; any skin discussion centers on whether those changes support or challenge skin integrity.\\n\\n## Why Tirzepatide might help you\\n\\n1. What keeps failing: Excess body weight maintains mechanical stretch on skin while metabolic factors sustain low-grade inflammation that impairs collagen maintenance.\\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP pathways linked to substantial weight reduction (typically 15-20% body weight in trials) and improved glycemic control.\\n3. Therefore for you: If excess weight or related inflammation forms part of the skin issue, Tirzepatide is examined because it addresses the metabolic load layer through fat reduction rather than directly altering skin cells or masking symptoms.\\n\\nWeight loss of this magnitude decreases compressive forces on tissues overall. For skin specifically, less subcutaneous fat can reveal or accentuate laxity in areas previously supported by adipose tissue. The same pathway may lower systemic inflammation that contributes to certain dermatologic conditions.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tirzepatide acts on the metabolic load and body weight layer. Any skin outcome—whether reduced inflammatory drive in conditions like psoriasis or increased laxity from rapid fat loss—stem","tokens_in":17476,"tokens_out":4066,"cost":0,"prev":"genesis","hash":"fa87b8ee6567bf33ed27812eded36383c200caffafc63d3fff5270100f33ce77"},{"ts":"2026-07-17T02:43:19.771Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-skin","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fa87b8ee6567bf33ed27812eded36383c200caffafc63d3fff5270100f33ce77","hash":"90c1b565e630d532f66eade36b1d0808d5091e38e4c090609c44196b28a7715e"}],"energy":{"passes":2,"tokens_in":17476,"tokens_out":4066,"tokens_total":21542,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"90c1b565e630d532f66eade36b1d0808d5091e38e4c090609c44196b28a7715e"},"posted_at":"2026-06-29T21:33:47.310Z","created_at":"2026-06-29T21:33:47.310Z","updated_at":"2026-07-17T02:43:19.771Z","machine":{"shape":"article.machine/v1","slug":"tirzepatide-skin","kind":"article","read":{"human":"https://miscsubjects.com/a/tirzepatide-skin","json":"https://miscsubjects.com/api/articles/tirzepatide-skin","bundle":"https://miscsubjects.com/api/articles/tirzepatide-skin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":6,"sources":8,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tirzepatide-skin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tirzepatide-skin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tirzepatide-skin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tirzepatide-skin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tirzepatide-skin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tirzepatide-skin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tirzepatide-skin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tirzepatide-skin","json":"/api/articles/tirzepatide-skin","markdown":"/api/articles/tirzepatide-skin/bundle?format=markdown","skill":"/api/articles/tirzepatide-skin/skill","topology":"/api/articles/tirzepatide-skin/topology","versions":"/api/articles/tirzepatide-skin/revisions","invocations":"/api/articles/tirzepatide-skin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tirzepatide-skin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"052d9d89474c1468de33d3a2ee713e17face412cc174f3ca6c74f186092e8150"}}}